Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

Autor: Katz, L. Jay, Cohen, John S., Batoosingh, Amy L., Felix, Carlos, Shu, Vincent, Schiffman, Rhett M.
Zdroj: In American Journal of Ophthalmology 2010 149(4):661-671
Databáze: ScienceDirect